Artificial Intelligence

Artificial Intelligence (AI) is transforming clinical pathology. The full potential of AI can only be achieved by the seamless integration of AI in clinical workflows to support pathologists. During this recorded presentation Aiforia’s...

Vancouver, BC, Canada, December 4, 2020 – ViewsIQ and GenerationsE are pleased to jointly announce their partnership for the worldwide sales representation of GenerationsE’s DeepScene product for AI-driven detection of colorectal cancer....

. Are you planning on attending Global Engage’s virtual 7th Digital Pathology & AI Congress: EU? If so, make sure to check out our presentation on December 3rd as well as our virtual booth. If you aren’t able to attend, don’t...

Collaborative program coordinated by Baylor College of Medicine is focused on addressing critical challenge of cancer overdiagnosis PHILADELPHIA - (BUSINESS WIRE) -- Proscia®, a leading provider of digital and computational pathology...

Aiforia, a leading provider of deep learning artificial intelligence (AI) solutions for image analysis across a variety of medical domains, has been granted U.S. Patent No. 10,803,586 by the United States Patent and Trademark Office (USPTO)....

We are excited to announce a newly published clinical study of TissueCypher® performance for predicting development of esophageal cancer in patients with Non-dysplastic Barrett’s Esophagus. The study, Independent Validation of a Tissue...